We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$791M
AUM Growth
-$79M
Cap. Flow
-$79.2M
Cap. Flow %
-10.01%
Top 10 Hldgs %
32.88%
Holding
105
New
11
Increased
29
Reduced
37
Closed
15

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$15.4M
2
LLY icon
Eli Lilly
LLY
+$12.5M
3
EHC icon
Encompass Health
EHC
+$11.3M
4
CAH icon
Cardinal Health
CAH
+$8.16M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$6.81M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.8M
2
UNH icon
UnitedHealth
UNH
+$18M
3
PRCT icon
Procept Biorobotics
PRCT
+$14.6M
4
MOH icon
Molina Healthcare
MOH
+$14.4M
5
MCK icon
McKesson
MCK
+$13.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMVT icon
101
Immunovant
IMVT
$8.24B
– –
-25,924
Closed -$443K
MEDP icon
102
Medpace
MEDP
$16.8B
– –
-3,800
Closed -$1.16M
MRK icon
103
Merck
MRK
$323B
– –
-33,000
Closed -$2.96M
VIR icon
104
Vir Biotechnology
VIR
$1.5B
– –
-200,000
Closed -$1.3M
ZBH icon
105
Zimmer Biomet
ZBH
$18.7B
– –
-87,250
Closed -$9.87M
1 2 3 4
5

Similar funds

ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return
AF
Ally Financial Detroit, Michigan $804M AUM 0.18% 1-Year Est. Return

Rhenman & Partners Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Rhenman & Partners Asset Management held 105 positions worth $791M, down 9.1% from $870M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $79.2M in Q2 2025, closing 15 positions and reducing 37 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Rhenman & Partners Asset Management opened a new position in Cardinal Health worth $9.24M.

  • Rhenman & Partners Asset Management's largest Q2 2025 buy was Cardinal Health: 55,000 shares worth $9.24M.
  • Rhenman & Partners Asset Management added most to Danaher in Q2 2025, an estimated $15.4M increase.
  • Rhenman & Partners Asset Management's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $18M.
  • Rhenman & Partners Asset Management fully exited Bristol-Myers Squibb in Q2 2025, selling an estimated $19.8M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 33% of its $791M portfolio in Q2 2025.
  • Rhenman & Partners Asset Management opened 11 new positions and closed 15 in Q2 2025.
  • Rhenman & Partners Asset Management's portfolio value fell 9.1% quarter-over-quarter to $791M.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.